4974 — Takara Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Takara Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	23,633	51,847	35,416	29,549	20,451
Net Total Accounts Receivable
Net Total Receivables	17,804	12,448	11,285	14,017	10,807
Total Inventory
Total Other Current Assets
Total Current Assets	68,141	77,569	62,759	57,679	44,878
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	36,395	40,956	49,075	56,954	62,744
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	115,712	129,202	121,252	125,334	133,658
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17,380	14,375	7,168	7,131	7,786
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	19,839	16,983	9,747	9,833	29,993
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	95,873	112,219	111,505	115,501	103,665
Total Liabilities & Shareholders' Equity	115,712	129,202	121,252	125,334	133,658
Total Common Shares Outstanding